Whole Blood Stem Cell Reinfusion and Escalated Dose Melphalan in Castration-Resistant Prostate Cancer: A Phase 1 Study

Phase 1 Study ◽

Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.2573 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 2573-2573

Author(s):

J. Shamash ◽

J. Jacob ◽

T. Powles ◽

S. Agrawal ◽

K. Mutsvangwa ◽

...

Keyword(s):

Prostate Cancer ◽

Stem Cell ◽

Phase I ◽

Whole Blood ◽

Blood Stem Cell ◽

PD28-12 A PHASE 1 STUDY OF A THIRD-GENERATION ONCOLYTIC HSV-1 G47Δ IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.399 ◽

2016 ◽

Vol 195 (4S) ◽

Cited By ~ 1

Author(s):

Hiroshi Fukuhara ◽

Yuta Takeshima ◽

Yukio Homma ◽

Yasushi Ino ◽

Tomoki Todo

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Third Generation ◽

Phase 1 Study ◽

Castration Resistant ◽

Hsv 1

Abstract P202: Initial findings from an ongoing first-in-human phase 1 study of the CBP/p300 inhibitor FT-7051 in men with metastatic castration-resistant prostate cancer

10.1158/1535-7163.targ-21-p202 ◽

2021 ◽

Author(s):

Andrew J. Armstrong ◽

Michael S. Gordon ◽

Melissa A. Reimers ◽

Arif Hussain ◽

Vaibhav G. Patel ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Phase 1 Study ◽

An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-019-01526-7 ◽

2019 ◽

Vol 24 (12) ◽

pp. 1596-1604 ◽

Cited By ~ 1

Author(s):

Tomohiro Tsuchiya ◽

Keiichiro Imanaka ◽

Yuki Iwaki ◽

Ryo Oyama ◽

Katsuyoshi Hashine ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Phase 1 ◽

Japanese Patients ◽

Open Label ◽

Phase 1 Study ◽

Androgen Receptor Antagonist ◽

Castration Resistant ◽

Open Label Phase

A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer

Investigational New Drugs ◽

10.1007/s10637-012-9857-z ◽

2012 ◽

Vol 31 (3) ◽

pp. 669-676 ◽

Cited By ~ 45

Author(s):

Gary Hudes ◽

Scott T. Tagawa ◽

Young E. Whang ◽

Ming Qi ◽

Xiang Qin ◽

...

Keyword(s):

Prostate Cancer ◽

Monoclonal Antibody ◽

Interleukin 6 ◽

Phase 1 ◽

Phase 1 Study ◽

Chimeric Monoclonal Antibody ◽

Pharmacokinetics, Antitumor Activity, and Safety of ODM-201 in Patients with Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer: An Open-label Phase 1 Study

European Urology ◽

10.1016/j.eururo.2015.09.046 ◽

2016 ◽

Vol 69 (5) ◽

pp. 834-840 ◽

Cited By ~ 26

Author(s):

Christophe Massard ◽

Heidi M. Penttinen ◽

Egils Vjaters ◽

Petri Bono ◽

Vilnis Lietuvietis ◽

...

Keyword(s):

Prostate Cancer ◽

Antitumor Activity ◽

Phase 1 ◽

Open Label ◽

Phase 1 Study ◽

Castration Resistant ◽

Open Label Phase

Editorial Comment on: A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2009.02.023 ◽

2009 ◽

Vol 56 (1) ◽

pp. 103-104 ◽

Cited By ~ 1

Author(s):

Henk G. van der Poel

Keyword(s):

Prostate Cancer ◽

Editorial Comment ◽

Phase 1 ◽

Low Risk ◽

Testosterone Replacement ◽

Phase 1 Study ◽

Phase 1 study with expansion cohorts of cabozantinib (C) + abiraterone (A) in metastatic castration resistant prostate cancer (mCRPC): Investigator-sponsored study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5037 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5037-5037

Author(s):

Christopher Sweeney ◽

Kathryn P. Gray ◽

Lauren Christine Harshman ◽

Mary-Ellen Taplin ◽

Amanda Fredericks Pace ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Phase 1 Study ◽

A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy

European Urology ◽

10.1016/j.eururo.2013.05.051 ◽

2014 ◽

Vol 65 (5) ◽

pp. 897-904 ◽

Cited By ~ 30

Author(s):

Manfred Wirth ◽

Axel Heidenreich ◽

Jürgen E. Gschwend ◽

Thierry Gil ◽

Stefan Zastrow ◽

...

Keyword(s):

Prostate Cancer ◽

Monoclonal Antibody ◽

Bone Metastases ◽

Phase 1 ◽

Phase 1 Study ◽

Castration Resistant ◽

Multicenter Phase ◽

Humanized Monoclonal Antibody ◽

Antibody Targeting

A Randomized Phase 1 Study of Testosterone Replacement for Patients with Low-Risk Castration-Resistant Prostate Cancer

European Urology ◽

10.1016/j.eururo.2009.02.022 ◽

2009 ◽

Vol 56 (1) ◽

pp. 97-104 ◽

Cited By ~ 43

Author(s):

Russell Szmulewitz ◽

Supriya Mohile ◽

Edwin Posadas ◽

Rangesh Kunnavakkam ◽

Theodore Karrison ◽

...

Keyword(s):

Prostate Cancer ◽

Phase 1 ◽

Low Risk ◽

Testosterone Replacement ◽

Phase 1 Study ◽